Form D — Everest Biolabs, Inc.
0002116676-26-000001 · filed Mar 11, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $5,650,000
- Total sold
- $4,350,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Everest Biolabs, Inc.
- CIK
- 2116676
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 204 SECOND AVE
WALTHAM, MA 02451 - Phone
- 6172140840
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
George Daaboul · Executive OfficerWaltham, MA Find on LinkedIn ↗
-
David Freedman · Executive OfficerWaltham, MA Find on LinkedIn ↗
-
David Walt · DirectorWaltham, MA Find on LinkedIn ↗
-
Paul Meister · DirectorWaltham, MA Find on LinkedIn ↗
-
Vinit Nijhawan · DirectorWaltham, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗